# Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis

> **NCT07074379** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 126 (estimated)

## Conditions studied

- Painless Chronic Pancreatitis

## Interventions

- **BEHAVIORAL:** Lifestyle modifications
- **DRUG:** Pancreatic enzyme (Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose , Metformin, Glimepirde Tablets, Insulin)
- **PROCEDURE:** Endoscopic Retrograde Cholangiopancreatography (ERCP) and/or Extracorporeal Shockwave Lithotripsy (ESWL)

## Key facts

- **NCT ID:** NCT07074379
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-21
- **Primary completion:** 2027-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07074379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07074379, "Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07074379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*